Shubhasree Banerjee is a Rheumatology/Immunology physician affiliated with Hospital of the University of Pennsylvania. OpenAlex indexes 40 publications with 2,405 citations (h-index 15); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3400 Spruce St
5 White
Philadelphia, PA 191044238
Telephone
215-662-2454Registry record last updated 24 Jul 2019.
Clinical trials
- An Open-Label Study of Effectiveness of Immunomodulatory Medications for Patients With Relapsing Polychondritis
Sponsor: University of Pennsylvania
- Longitudinal Study for Relapsing Polychondritis
Sponsor: University of Pennsylvania
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- NS Pharma, Inc.Program year20232 payments
- Amgen Inc.Program year20231 payment
- Amgen Inc.Program year20222 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
53.8%Folate Analog Metabolic Inhibitor12.9%Methotrexate90%Rasuvo10%Part D<11 patientsTNF inhibitor12.6%Humira Pen33%Enbrel Sureclick29%Humira(Cf) Pen16%Enbrel15%Humira7%Part D<11 patients+ 7 more classes in this area
Nervous system
15%Gabapentinoids7.9%Gabapentin100%Part D≥17 patientsCholinergic Receptor Agonist2.6%Cevimeline Hcl100%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
14.1%Corticosteroid13.2%Prednisone100%Part D≥40 patientsAntidiarrheal microorganisms0.9%Folic Acid100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- ABS0129 EFFICACY OF A BD2-SELECTIVE BET INHIBITOR IN ANIMAL MODELS OF RHEUMATOID ARTHRITIS BY INHIBITION OF NF-KB DRIVEN INFLAMMATORY PATHWAYS
Annals of the Rheumatic Diseases
2025 - POS1122 The therapeutic potential for JAK inhibitors for immune-related adverse events from checkpoint inhibitors–a review of the literature
Annals of the Rheumatic Diseases
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Mohamed Gad, MD, MPH
Hospital of the University of Pennsylvania
Selina Luger, MD
Hospital of the University of Pennsylvania
Simin Goral, MD
Hospital of the University of Pennsylvania
Katherine Steele, MD
Hospital of the University of Pennsylvania
Marc Hochberg, MD
University of Maryland School of Medicine
Michelle Petri, MD
Johns Hopkins University School of Medicine
Dinesh Khanna, MD
University of Michigan
Matthew Liang, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”